Perinatal complications, lipid peroxidation, and mental health problems in a large community pediatric sample

Carregando...
Imagem de Miniatura
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2017
Editora
SPRINGER
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
MANSUR, Rodrigo B.
CUNHA, Graccielle R.
ASEVEDO, Elson
ZUGMAN, Andre
RIOS, Adiel C.
SALUM, Giovanni A.
PAN, Pedro M.
GADELHA, Ary
LEVANDOWSKI, Mateus L.
BELANGERO, Sintia I.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, v.26, n.5, p.521-529, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Replicated evidence indicates that perinatal complications are associated with increased markers of oxidative stress and with mental health problems in children. However, there are fewer reports on the impact of perinatal complications in later phases of development. We aimed to investigate the estimated effects of perinatal complications on levels of lipid peroxidation and on psychopathology in children and adolescents. The study is part of the High Risk Cohort Study for Psychiatric Disorders; the population was composed by 554 students, 6-14 years of age. Serum levels of malondialdehyde, a product of lipid peroxidation, were measured by the TBARS method. A household interview with parents and caregivers was conducted and included inquiries about perinatal history, the Child Behavior Checklist (CBCL), and parent's evaluation, using the Mini International Psychiatric Interview (MINI). We created a cumulative risk index, conceptualized as each individual's cumulative exposure to perinatal complications. Results indicate that perinatal complications were associated with higher levels of TBARS. After adjusting for age, gender, socio-economic status, CBCL total problems score, parental psychopathology, and childhood maltreatment, children exposed to 3 or more perinatal complications had an 26.9% (95% CI 9.9%, 46.6%) increase in TBARS levels, relative to the unexposed group. Exploratory mediation analysis indicated that TBARS levels partially mediated the association between perinatal complications and externalizing problems. In conclusion, an adverse intrauterine and/or early life environment, as proxied by the cumulative exposure to perinatal complications, was independently associated with higher levels of lipid peroxidation in children and adolescents.
Palavras-chave
Oxidative stress, Lipid peroxidation, Perinatal complications, Adverse early life environment, Childhood, Psychopathology
Referências
  1. Ardalic D, 2014, ADV CLIN EXP MED, V23, P575
  2. Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x
  3. Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012
  4. Bizon A, 2011, REPROD TOXICOL, V32, P360, DOI 10.1016/j.reprotox.2011.08.007
  5. Black CN, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.5
  6. Black CN, 2015, PSYCHONEUROENDOCRINO, V51, P164, DOI 10.1016/j.psyneuen.2014.09.025
  7. Bordin IA, 2013, CAD SAUDE PUBLICA, V29, P13, DOI 10.1590/S0102-311X2013000100004
  8. Bosch NM, 2012, PSYCHONEUROENDOCRINO, V37, P1439, DOI 10.1016/j.psyneuen.2012.01.013
  9. Bouret S, 2015, PHYSIOL REV, V95, P47, DOI 10.1152/physrev.00007.2014
  10. Brown NC, 2014, PSYCHIAT RES, V218, P61, DOI 10.1016/j.psychres.2014.04.005
  11. Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
  12. Coccaro EF, 2016, BIOL PSYCHIAT, V79, P127, DOI 10.1016/j.biopsych.2014.01.014
  13. Cunha GR, 2016, ACTA PSYCHIAT SCAND, V133, P122, DOI 10.1111/acps.12453
  14. D'Onofrio BM, 2013, JAMA PSYCHIAT, V70, P1231, DOI 10.1001/jamapsychiatry.2013.2107
  15. deRosset L, 2015, ANN EPIDEMIOL, V25, P539, DOI 10.1016/j.annepidem.2015.01.003
  16. Entringer S, 2008, AM J OBSTET GYNECOL, V199, P491
  17. Entringer S, 2009, HORM BEHAV, V55, P292, DOI 10.1016/j.yhbeh.2008.11.006
  18. Falciglia HS, 2003, AM J PERINAT, V20, P97, DOI 10.1055/s-2003-38315
  19. Ferencz A, 2015, REPROD TOXICOL, V53, P10, DOI 10.1016/j.reprotox.2015.02.008
  20. Ferguson KK, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.08.007
  21. Finkel D, 2000, J AGING HEALTH, V12, P47, DOI 10.1177/089826430001200103
  22. Flatow J, 2013, BIOL PSYCHIAT, V74, P400, DOI 10.1016/j.biopsych.2013.03.018
  23. Flouri E, 2007, J AM ACAD CHILD PSY, V46, P1651, DOI 10.1097/chi.0b013e318156a81a
  24. Foley DL, 2001, AM J MED GENET, V105, P426, DOI 10.1002/ajmg.1402
  25. Fraguas D, 2012, SCHIZOPHR RES, V137, P58, DOI 10.1016/j.schres.2012.01.040
  26. Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473
  27. Guney E, 2015, PSYCHIAT RES, V229, P310, DOI 10.1016/j.psychres.2015.07.003
  28. Gustafsson PE, 2014, AM J PUBLIC HEALTH, V104, P904, DOI 10.2105/AJPH.2013.301707
  29. Howlader MZH, 2009, J TROP PEDIATRICS, V55, P363, DOI 10.1093/tropej/fmp025
  30. Hsieh TT, 2012, REPROD SCI, V19, P505, DOI 10.1177/1933719111426601
  31. Hussein MH, 2010, FREE RADICAL RES, V44, P422, DOI 10.3109/10715760903548245
  32. Ivanova MY, 2007, J CLIN CHILD ADOLESC, V36, P405
  33. Jerrell JM, 2010, J CLIN PSYCHIAT, V71, P1518, DOI 10.4088/JCP.09m05585ora
  34. Khoubnasabjafari M, 2015, BIOIMPACTS, V5, P123, DOI 10.15171/bi.2015.20
  35. Kieling C, 2013, J CHILD PSYCHOL PSYC, V54, P298, DOI 10.1111/jcpp.12022
  36. Lahat A, 2015, DEV PSYCHOPATHOL, V27, P181, DOI 10.1017/S0954579414000662
  37. Lee Yuan-Shun, 2005, Chang Gung Med J, V28, P846
  38. Lin WM, 2014, BIOMED RES INT, DOI 10.1155/2014/340936
  39. Martinez-Cengotitabengoa M, 2014, SCHIZOPHR RES, V156, P23, DOI 10.1016/j.schres.2014.03.025
  40. Negi R, 2012, J MATERN-FETAL NEO M, V25, P1338, DOI 10.3109/14767058.2011.633672
  41. Perez-Cornago A, 2014, CLIN NUTR, V33, P1061, DOI 10.1016/j.clnu.2013.11.011
  42. Perkins DO, 2015, SCHIZOPHRENIA BULL, V41, P419, DOI 10.1093/schbul/sbu099
  43. Peterside IE, 2003, AM J PHYSIOL-ENDOC M, V285, pE1258, DOI 10.1152/ajpendo.00437.2002
  44. Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879
  45. Salum GA, 2015, INT J METH PSYCH RES, V24, P58, DOI 10.1002/mpr.1459
  46. Selak MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE130, DOI 10.1152/ajpendo.00322.2002
  47. Shalev I, 2014, PEDIATRICS, V134, pE1315, DOI 10.1542/peds.2014-1669
  48. Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200
  49. Slopen N, 2015, PSYCHONEUROENDOCRINO, V51, P403, DOI 10.1016/j.psyneuen.2014.10.016
  50. STANTON WR, 1991, PEDIATRICS, V88, P954
  51. STANTON WR, 1989, AUST PAEDIATR J, V25, P130
  52. Turpin CA, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0624-y
  53. van Winkel R, 2013, CAN J PSYCHIAT, V58, P44
  54. Versace A, 2014, MOL PSYCHIATR, V19, P200, DOI 10.1038/mp.2012.188
  55. Vitale G, 2013, NAT REV ENDOCRINOL, V9, P228, DOI 10.1038/nrendo.2013.29
  56. Wender-Ozegowska E, 2004, FREE RADICAL RES, V38, P795, DOI 10.1080/10715760410001700479
  57. WILLS ED, 1966, BIOCHEM J, V99, P657